Cover Image
Market Research Report

Drug Discovery Informatics Market - Growth, Trends, and Forecast (2019 - 2024)

Published by Mordor Intelligence LLP Product code 871391
Published Content info 114 Pages
Delivery time: 2-3 business days
Back to Top
Drug Discovery Informatics Market - Growth, Trends, and Forecast (2019 - 2024)
Published: May 1, 2019 Content info: 114 Pages

Market Overview

The cost of research and development in drug discovery is rising significantly. Most clinical trials for drugs are sponsored by pharmaceutical companies, who spend millions of money for drug development which in turn is the primary reason why their products are so expensive. Drug discovery is the area of research and development that accounts for the most amount of time and money. The time frame can range from 4-25 years and costs can be thousands of millions of dollars. The healthcare industry was facing major challenges such as increasing costs, unacceptable error rates, and dissatisfied patients and providers. Drug Discovery Informatics uses sophisticated bioinformatics algorithms to process data related to drug, disease, protein, pathway, gene expression, sequence data and extend the flexible architecture to build new customized approaches and algorithms for diverse aspects of drug discovery which would help to minimize the cost for drug development. The other factor such as pharmaceutical companies gaining more interest in drug discovery and urgent need to limit the drug discovery and development cost are driving the Drug Discovery Informatics Market to grow.

Scope of the Report

The information technology supporting the drug discovery process is known as drug discovery bioinformatics. With the vast amount of biochemical data generated from experiments conducted by research laboratories around the globe, there is a strong demand for software to analyze and manage the data effectively which will drive the market studied.

Key Market Trends

Pharmaceutical and Biotechnology Companies is Expected to Grow with High CAGR in the Forecasted Period

Informatics analysis in drug discovery not only accelerate drug target identification and drug candidate screening and refinement but also facilitate characterization of side effects and predict drug resistance. High-throughput data such as genomic, epigenetic, genome architecture, cistromic, transcriptomic, proteomic, and ribosome profiling data have all made a significant contribution to mechanism-based drug discovery. Informaticians in drug discovery use high-throughput molecular data in comparisons between symptom-carriers (patients, animal disease models, cancer cell lines, etc.) and normal controls. Also, only 10 percent of drug molecules which are identified in research make it through development which means that many potential drugs do not make it to market, and expensive time and resources are invested m molecules that will generate no revenue. So, simulation and informatics can significantly increase the odds by improving the efficiency of drug development, cutting costs, and improving margins for pharmaceutical and biotechnology companies. Thus increasing the application of Informatics in drug discovery is augmenting the growth of the market. Also, major pharmaceutical companies have established high throughput screening facilities and have invested in automation to screen large compound libraries. There is pharmaceutical bioinformatics which is a new discipline in the area of the genomics revolution. It is central to biomedicine with application in areas like pharmacy, medicine, biology, and medicinal chemistry which will help in the growth of the market in future forecast.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. In North America region, the United States holds the largest market share and this is due to the increasing R&D on drug discovery and technological advancements in data mining and analytic which has helped the growth of the Drug Discovery Informatics market in the country. The advancement terms of informatics research are well supported by the healthcare IT sectors and demand for new drugs in lesser timeline and cost for infrastructure. These factors drive the importance and market growth in the North America region better than other parts of the world.

Competitive Landscape

The Drug Discovery Informatics market is competitive and consists of a few major players. In terms of market share, these major players currently dominate the market. Some of the major players of the market are GVK Biosciences, Infosys, IBM, and PerkinElmer among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support
Table of Contents
Product Code: 57046

Table of Contents


  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Technological Advancements in Data Mining and Analytics
    • 4.2.2 Increasing R&D on Drug Discovery
  • 4.3 Market Restraints
    • 4.3.1 High Pricing and Setup Cost of Informatics Software
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 Function
    • 5.1.1 Sequencing & Target Data Analysis
    • 5.1.2 Docking
    • 5.1.3 Molecular Modelling
    • 5.1.4 Libraries & Database Preparation
    • 5.1.5 Others
  • 5.2 End User
    • 5.2.1 Pharmaceutical and Biotechnology Companies
    • 5.2.2 Contract Research Organizations (CROS)
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • US
      • Canada
      • Mexico
    • 5.3.2 Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.3.3 Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South korea
      • Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • 5.3.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Collaborative Drug Discovery
    • 6.1.2 Dassault Systmes
    • 6.1.3 GVK Biosciences
    • 6.1.4 IBM
    • 6.1.5 Infosys
    • 6.1.6 IO Informatics
    • 6.1.7 Jubilant Life Sciences
    • 6.1.8 Novo Informatics
    • 6.1.9 Perkinelmer
    • 6.1.10 Thermo Fisher Scientific


Back to Top